- Home
- FCAP vs MCRB Comparison
FCAP vs MCRB Comparison
Compare FCAP & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCAP
- MCRB
- Stock Information
- Founded
- FCAP 1891
- MCRB 2010
- Country
- FCAP United States
- MCRB United States
- Employees
- FCAP N/A
- MCRB N/A
- Industry
- FCAP Savings Institutions
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- FCAP Finance
- MCRB Health Care
- Exchange
- FCAP Nasdaq
- MCRB Nasdaq
- Market Cap
- FCAP 161.2M
- MCRB 81.2M
- IPO Year
- FCAP 1999
- MCRB 2015
- Fundamental
- Price
- FCAP $48.57
- MCRB $6.96
- Analyst Decision
- FCAP
- MCRB Hold
- Analyst Count
- FCAP 0
- MCRB 5
- Target Price
- FCAP N/A
- MCRB $73.67
- AVG Volume (30 Days)
- FCAP 14.4K
- MCRB 141.1K
- Earning Date
- FCAP 04-25-2025
- MCRB 05-07-2025
- Dividend Yield
- FCAP 2.50%
- MCRB N/A
- EPS Growth
- FCAP 2.61
- MCRB N/A
- EPS
- FCAP 3.65
- MCRB 0.03
- Revenue
- FCAP $42,869,000.00
- MCRB N/A
- Revenue This Year
- FCAP N/A
- MCRB N/A
- Revenue Next Year
- FCAP N/A
- MCRB N/A
- P/E Ratio
- FCAP $12.59
- MCRB $208.01
- Revenue Growth
- FCAP 6.35
- MCRB N/A
- 52 Week Low
- FCAP $27.10
- MCRB $7.18
- 52 Week High
- FCAP $53.85
- MCRB $30.60
- Technical
- Relative Strength Index (RSI)
- FCAP 60.52
- MCRB 32.32
- Support Level
- FCAP $43.00
- MCRB $8.92
- Resistance Level
- FCAP $53.85
- MCRB $9.97
- Average True Range (ATR)
- FCAP 2.85
- MCRB 1.10
- MACD
- FCAP 0.07
- MCRB -0.01
- Stochastic Oscillator
- FCAP 60.15
- MCRB 1.51
About FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.